Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frauke Bataille

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Molecular Medicine (Cambridge, Mass.)|December 15, 2010
Liver regeneration associated protein (ALR) exhibits antimetastatic potential in hepatocellular carcinomaRania Dayoub, Hannah Wagner, Frauke Bataille, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 23, 2005
In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased liversClaus Hellerbrand, Frauke Bataille, Jacqueline Schlegel, et al.
Cancer|November 6, 2003
Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumorsThomas Vogt, Christian Hafner, Klaus Bross, et al.
Cancer Science|January 30, 2009
Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinomaThomas Amann, Frauke Bataille, Thilo Spruss, et al.
Carcinogenesis|August 6, 2005
Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinomaClaus Hellerbrand, Marcus Mühlbauer, Susanne Wallner, et al.
Cancer Biomarkers : Section a of Disease Markers|May 25, 2007
Bone morphogenetic protein 7 (BMP7) expression is a potential novel prognostic marker for recurrence in patients with primary melanomaTanja Rothhammer, Peter J Wild, Stefanie Meyer, et al.
World Journal of Gastroenterology|July 5, 2005
Ephrin-B2 is differentially expressed in the intestinal epithelium in Crohn's disease and contributes to accelerated epithelial wound healing in vitroChristian Hafner, Stefanie Meyer, Thomas Langmann, et al.
Experimental Dermatology|May 27, 2010
Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanomaStefanie Meyer, Peter J Wild, Thomas Vogt, et al.
Cells|January 23, 2020
Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver InjuryJudith Sommer, Christoph Dorn, Erwin Gäbele, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 20, 2004
Strong expression of methylthioadenosine phosphorylase (MTAP) in human colon carcinoma cells is regulated by TCF1/[beta]-cateninFrauke Bataille, Gerhard Rogler, Katharina Modes, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Molecular Medicine (Cambridge, Mass.)|December 15, 2010
Liver regeneration associated protein (ALR) exhibits antimetastatic potential in hepatocellular carcinomaRania Dayoub, Hannah Wagner, Frauke Bataille, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 23, 2005
In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased liversClaus Hellerbrand, Frauke Bataille, Jacqueline Schlegel, et al.
Cancer|November 6, 2003
Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumorsThomas Vogt, Christian Hafner, Klaus Bross, et al.
Cancer Science|January 30, 2009
Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinomaThomas Amann, Frauke Bataille, Thilo Spruss, et al.
Carcinogenesis|August 6, 2005
Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinomaClaus Hellerbrand, Marcus Mühlbauer, Susanne Wallner, et al.
Cancer Biomarkers : Section a of Disease Markers|May 25, 2007
Bone morphogenetic protein 7 (BMP7) expression is a potential novel prognostic marker for recurrence in patients with primary melanomaTanja Rothhammer, Peter J Wild, Stefanie Meyer, et al.
World Journal of Gastroenterology|July 5, 2005
Ephrin-B2 is differentially expressed in the intestinal epithelium in Crohn's disease and contributes to accelerated epithelial wound healing in vitroChristian Hafner, Stefanie Meyer, Thomas Langmann, et al.
Experimental Dermatology|May 27, 2010
Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanomaStefanie Meyer, Peter J Wild, Thomas Vogt, et al.
Cells|January 23, 2020
Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver InjuryJudith Sommer, Christoph Dorn, Erwin Gäbele, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 20, 2004
Strong expression of methylthioadenosine phosphorylase (MTAP) in human colon carcinoma cells is regulated by TCF1/[beta]-cateninFrauke Bataille, Gerhard Rogler, Katharina Modes, et al.
Pageof 5